Trump ad­min­is­tra­tion hikes Medicare Ad­van­tage pay­ments by $25B

Last month
Health Tech

HHS says it may re­vis­it an­ti-obe­si­ty drug poli­cies af­ter drop­ping Biden-era pro­pos­al

Last month
Pharma
Marketing

Min­neso­ta fed­er­al judge dis­miss­es chal­lenge from Ab­b­Vie, As­traZeneca to state's 340B law

Last month
Pharma
Law

PureTech re­jects cash ex­it pro­pos­al from Nordic Cap­i­tal, in­vest­ment firm says it won't make an of­fer

Last month
Deals
Pharma

Rare dis­ease hub at CDER and CBER faces new re­al­i­ty with staff crunch

Last month
Pharma
FDA+

‘This is self-in­flict­ed’: Leerink’s David Risinger on the mar­ket shock and hits to bio­phar­ma

Last month
People
FDA+

Drug tool and pack­ag­ing mak­ers to feel brunt of Trump tar­iffs, an­a­lysts say

Last month
Pharma
Manufacturing

RFK Jr. won’t tes­ti­fy be­fore key Sen­ate com­mit­tee this week on HHS over­haul

Last month
Pharma
FDA+

Stock mar­ket melts down over Trump’s tar­iffs, and biotech's pain keeps grow­ing

Last month
Financing
Pharma

Im­munol­o­gy start­up RayThera se­cures $110M in Se­ries A raise

Last month
Financing
Startups

Lex­eo dis­clos­es new da­ta for heart drug; Spark Ther­a­peu­tics to lay off work­ers

Last month
News Briefing

ADC start­up Du­al­i­ty­Bio seeks Hong Kong IPO amid pre­car­i­ous mar­ket

Last month
Financing
Startups

Rhythm touts Phase 3 win for rare obe­si­ty drug in peo­ple with brain dam­age

Last month
R&D
Pharma

Cell and gene ther­a­py CD­MO Am­pli­fy­Bio shuts down over 's­carci­ty' of fund­ing

Last month
Cell/Gene Tx
Manufacturing

GSK’s newest neu­ro pact is with ABL Bio, a Sanofi-part­nered South Ko­re­an biotech

Last month
Deals
Pharma

Q&A: A con­ver­sa­tion with GLP-1 co-dis­cov­er­er Jens Ju­ul Holst on the fu­ture of in­cretin-based drugs

Last month
People

Q&A: David Liu talks about sci­ence un­der pres­sure, teas­es “dis­ease-ag­nos­tic” gene edit­ing

Last month
People

Staff cuts sweep across FDA; Tar­iff roll­out rais­es ques­tions; The R&D 15 is back; and more

Last month
Weekly

Trump ad­min­is­tra­tion leaves obe­si­ty cov­er­age ex­pan­sion out of new Medicare rule

Last month
Pharma
FDA+

GSK and Pfiz­er re­solve RSV vac­cine patent fight

Last month
Pharma
Law

Marks was asked to pro­vide non-ex­is­tent vac­cine risk da­ta: WSJ

Last month
FDA+

No­vavax’s held-up ap­proval pack­age may sig­nal warn­ing for Covid vac­cine mak­ers

Last month
R&D
Pharma

FTC chair­man seeks to re­vive PBM case

Last month
Pharma
Law

Chi­na's re­tal­ia­to­ry tar­iffs on US could mean more head­winds for drug­mak­ers

Last month
China
Pharma
First page Previous page 17181920212223 Next page Last page
A service from the Financial Times